TriSalus Life Sciences, Inc. Increase (Decrease) in Income Taxes Payable
TriSalus Life Sciences, Inc. (TLSI) reported Increase (Decrease) in Income Taxes Payable of $2.84 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2023-08-02
- TriSalus Life Sciences, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-06-30 was -$24.28K.
- TriSalus Life Sciences, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-03-31 was $27.12K.
- TriSalus Life Sciences, Inc. increase (decrease) in income taxes payable for the quarter ending 2022-12-31 was -$135.63K.
- TriSalus Life Sciences, Inc. increase (decrease) in income taxes payable for the quarter ending 2022-09-30 was $135.28K.
- TriSalus Life Sciences, Inc. increase (decrease) in income taxes payable for fiscal 2022 was $27.85K.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$24.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.84K 10-Q · filed 2023-08-02 | -$132.79K derived: sum of 3 quarters · filed 2023-08-02 | $2.49K derived: sum of 4 quarters · filed 2023-08-02 |
| 2023-03-31 | $27.12K 10-Q · filed 2023-05-12 | -$108.51K derived: sum of 2 quarters · filed 2023-05-12 | $26.77K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2022-12-31 | -$135.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$348.00 derived: sum of 2 quarters · filed 2023-03-22 | $27.85K 10-K · filed 2023-03-22 | |
| 2022-09-30 | $135.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $163.49K 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $28.20K 10-Q · filed 2023-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |